Jeffrey Chapek, DO
Orthopaedic Surgery · Edgewood, KYNPI 1669975629
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (31.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 73.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $19,033 and has fallen 82.9% since, to $3,246 in 2025.
Across 117 payments — averaging $321.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$28K
- Zimmer Biomet$5K
- Stryker$2K
- Novus Surgical Solutions LLC$1K
- Johnson & Johnson$325
- Baxter Healthcare$277
- plus $625 from 6 others
What the payments were for
- Grants$11,79531%
- Travel & lodging$8,47423%
- Food & beverage$6,09716%
- Education$11,23430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 35 | $27,800 |
| Zimmer Biomet | 38 | $5,444 |
| Stryker | 27 | $1,870 |
| Novus Surgical Solutions LLC | 2 | $1,257 |
| Johnson & Johnson | 5 | $325 |
| Baxter Healthcare | 2 | $277 |
| Microport Orthopedics Inc | 2 | $184 |
| Next Science LLC | 1 | $164 |
| Medical Device Business Services, Inc. | 2 | $117 |
| Novus Surgical Consultants | 1 | $73 |
| Innovation Technologies Inc | 1 | $64 |
| Solventum Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$6,554
- REAL INTELLIGENCE$5,346
- RI.HIP NAVIGATION$3,447
- JOURNEY$3,326
- OR3O Dual Mobility$1,614
- Taperloc$1,134
- MAKO$1,119
- POLARSTEM$688
- Persona$568
- TITAN$539
- Avenir$503
- HIP7$446
- ROSA$384
- TISSEEL$277
- Comprehensive Shoulder System$276
- OSS Orthopedic Salvage System$258
- EVOS$243
- INSIGNIA$174
- Xperience$164
- BlastX$164
How this compares
$37,600 in reported general payments places this provider in the 85th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 16 | $830 |
| Diclofenac Sodium | 12 | $281 |
| Meloxicam | 76 | $119 |
| Methylprednisolone | 16 | $110 |
| Tramadol Hcl | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Edgewood
- Arthur MalkaniLouisville$9.6M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.5M
- Akbar NawabLouisville$1M
- Samer HasanCrestview Hills$976K
- Phillip SingerBowling Green$816K
- Brent MorrisLexington$815K
- Joseph GreeneLouisville$581K
- Raymond GreiweFlorence$546K
- Clint HillPaducah$516K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.